Epilepsy (EP) and congenital heart disease (CHD) are two apparently unrelated diseases that nevertheless display substantial mutual comorbidity. Thus, whilst congenital heart defects are associated with an elevated risk of developing epilepsy, the incidence of epilepsy in CHD patients correlates with CHD severity. Although genetic determinants have been postulated to underlie the comorbidity of EP and CHD, the precise genetic etiology is unknown. We performed variant and gene association analyses on EP and CHD patients separately, using whole exomes of genetically identi ed Europeans from the UK Biobank and Mount Sinai BioMe Biobank. We prioritized biologically plausible candidate genes and investigated the enriched pathways and other identi ed comorbidities by biological proximity calculation, pathway analyses, and gene-level phenome-wide association studies. Our variant-and gene-level results point to the Voltage-Gated Calcium Channels (VGCC) pathway being a unifying framework for EP and CHD comorbidity. Additionally, pathwaylevel analyses indicated that the functions of disease-associated genes partially overlap between the two disease entities. Lastly, phenome-wide association analyses of prioritized candidate genes revealed that cerebral blood ow and ulcerative colitis constitute the two main traits associated with both EP and CHD.